Physician profile
Mackenzie A Courtney
NPI 1083190599
$7,150.12
in general payments reported to CMS, 2019-2025
29 companies · $3,844 in 2025
The $3,844 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7.67 · 2023: $1,014 · 2024: $2,284 · 2025: $3,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,010 · Travel and Lodging: $3,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,009.60 |
| Travel and Lodging | $3,132.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,635.10 | 2024-2025 | Indigo System |
| Medtronic, INC. | $948.32 | 2024-2025 | Linq II |
| Biosense Webster, INC. | $302.22 | 2024-2025 | Carto 3, Nuvision Ice Catheter |
| Merck Sharp & Dohme LLC | $297.76 | 2023-2025 | Verquvo, Winrevair, Lagevrio |
| Pfizer INC. | $192.42 | 2023-2024 | |
| Boston Scientific Corporation | $186.37 | 2023-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.34 | 2023-2024 | Jardiance |
| Abbott Laboratories | $170.22 | 2025 | Coroflow, Jeti Peripheral Catheter, Jot Dx |
| Novartis Pharmaceuticals Corporation | $144.45 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $115.03 | 2023-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $105.44 | 2023-2024 | Xarelto |
| Tactile Systems Technology INC | $101.57 | 2025 | Flexitouch Plus, Nimbl |
| Baxter Healthcare | $94.82 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $94.22 | 2023-2024 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $69.63 | 2023-2024 | Wainua, Farxiga, Lokelma |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $65.41 | 2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.85 | 2023-2024 | Lifevest |
| Cvrx, INC. | $51.42 | 2023 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $48.34 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $42.84 | 2023-2024 | Onpattro |
| Scpharmaceuticals INC. | $42.65 | 2024 | |
| Sanofi-Aventis U.S. LLC | $40.88 | 2023-2024 | |
| Abiomed | $31.73 | 2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $30.86 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $29.05 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Daiichi Sankyo INC. | $27.36 | 2023 | Injectafer |
| Kiniksa Pharmaceuticals, LTD. | $19.88 | 2023 | Arcalyst |
| Philips North America LLC | $15.27 | 2025 | IV Other |
| Genentech USA, INC. | $7.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Courtney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.